News

Location: Home > News

2026-10-29

New Arrival Alert! Ferulic Acid Series Impurity Reference Standards are now online! Spot inventory and preferential prices are unlocked simultaneously!

We have carefully launched the ‌cis-ferulic acid impurity reference standard‌ to help improve pharmaceutical quality!...

29

2026-10

More

2026-10-19

[Featured Product] Filling the R&D Gap: Etrasimod Impurity Reference Standards Just Launched, Covering Every Consistency-Evaluation Need!

Changzhou Xianglong Pharmaceutical Technology Co., Ltd.‌ has been deeply engaged in pharmaceutical impurity reference standards for decades. Backed by the ‌dual-system accreditation‌ held by its subsidiary ‌Longhui Biotechnology‌ — ‌CNAS ISO/IEC 17025‌ (competence of testing and ...

19

2026-10

More

2026-09-15

【News Interpretation‌】Focus on NMPA Announcement No.86: Consistency Evaluation of Eye Drops Launched, Changzhou Xianglong Rolls Out Full-Chain Quality Control Reference Material Solutions Simultaneously!

Under the strict regulatory system for the consistency evaluation of eye drops, selecting a compliant reference standard manufacturer is a top priority!...

15

2026-09

More

2026-09-07

[News Analysis] From a 380 Million Penalty Fine to Febuxostat Impurity K: Compliant Reference Standards as the Invisible Defense for Pharmaceuticals and Food Safety!

Compliance reference standards serve as the invisible defense line for drug and food safety!...

07

2026-09

More

2026-08-24

【Good News】Accurate measurement, well done! Xianglong Pharmaceutical has been awarded CNAS 17034 accreditation, and with CNAS 17025 accreditation and GBW (E) national standards, it has built a "dual system+national standard" quality moat!

Unite with one heart and create brilliance together!...

24

2026-08

More

2026-08-14

[Xianglong Classroom] Analysis of Impurity Spectrum in Ondansetron: The Chemical Game Between the Carbazole Core and the Imidazole Side Chain!

Welcome to purchase our products....

14

2026-08

More

2026-08-10

【New Product Recommendation】Heavyweight Launch of Tribenzoglycoside-Related Impurity Reference Standards, One-Stop Solution for R&D Quality Control Challenges!

We have meticulously selected and launched a series of tribenzoyl glucoside impurity reference standards to enhance pharmaceutical quality!...

10

2026-08

More

2026-07-22

【New Product Recommendation】Seize the Opportunity in RAS Target Drug Development: High-Purity Impurity Reference Standards to Safeguard the Quality Research of Your Innovative Drugs!

The RAS target is a highly significant oncogenic gene locus in the field of cancer treatment. Once the protein it controls mutates, it can cause uncontrolled cell growth, and approximately 30% of human cancers are associated with it....

22

2026-07

More

2026-07-10

【Quality Product Recommendation】Stuck on the Ishalumab project timeline? Choose the right impurity reference standard to save three months of detours.

Ixazomib (trade name: Ninlaro) is the world's first orally administered, highly selective proteasome inhibitor, classified as a targeted anti-tumor prescription drug. Approved for marketing in China in 2018, it has been included in the national medical insurance list (Category B)...

10

2026-07

More

2026-06-25

Igniting the Stage! Changzhou Xianglong Pharmaceutical Concludes Successfully at CPHI China 2026!

Keep moving forward, thank you to your colleagues! See you at our next exhibition!...

25

2026-06

More

E-mail